http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113671064-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2030-045
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-34
filingDate 2021-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2022-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-113671064-B
titleOfInvention Detection method for quantitatively analyzing blood concentration of amlexanox in plasma
abstract The invention discloses a detection method for quantitatively analyzing blood concentration of amlexanox in plasma, which comprises the steps of taking blood from the orbit of a Wistar rat after the amlexanox gavage treatment, centrifuging to obtain plasma, mixing the plasma with acetonitrile solution containing an internal standard, separating a detected plasma sample by using a liquid chromatography-mass spectrometry system and a mass spectrum as a detection system, and detecting the detected plasma sample after gradient elution, wherein ions for quantitative analysis are respectively amlexanox: m/z 299.2 → 281.2, internal standard IS: m/z 259.9 → 116.1, amlexanox collision energy is 19V and internal standard collision energy is 15V. The invention has the advantages of strong specificity, high sensitivity, simple and quick sample pretreatment, short analysis period and the like, and is suitable for blood concentration determination, pharmacokinetic research and tissue distribution research of amlexanox in blood plasma.
priorityDate 2021-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9913
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID284
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453852937
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2161
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6342
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID37768
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554785
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559502
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503345
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591862
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22222221
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419500696
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407631466

Total number of triples: 39.